ATE356147T1 - Antikörper zur vorbeugung und behandlung von e. coli aeec krankheiten - Google Patents

Antikörper zur vorbeugung und behandlung von e. coli aeec krankheiten

Info

Publication number
ATE356147T1
ATE356147T1 AT02708075T AT02708075T ATE356147T1 AT E356147 T1 ATE356147 T1 AT E356147T1 AT 02708075 T AT02708075 T AT 02708075T AT 02708075 T AT02708075 T AT 02708075T AT E356147 T1 ATE356147 T1 AT E356147T1
Authority
AT
Austria
Prior art keywords
aeec
preventing
antibodies
virulence
coli
Prior art date
Application number
AT02708075T
Other languages
English (en)
Inventor
John M Fairbrother
Josee Harel
Isabelle Batisson
Francis Girard
Marie-Pierre Guimond
Original Assignee
Valorisation Rech Soc En Comma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valorisation Rech Soc En Comma filed Critical Valorisation Rech Soc En Comma
Application granted granted Critical
Publication of ATE356147T1 publication Critical patent/ATE356147T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1232—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT02708075T 2001-03-15 2002-03-14 Antikörper zur vorbeugung und behandlung von e. coli aeec krankheiten ATE356147T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002339436A CA2339436A1 (fr) 2001-03-15 2001-03-15 Production d'anticorps contre les facteurs de virulence associes aux souches d'escherichia coli aeec, et leur utilisation

Publications (1)

Publication Number Publication Date
ATE356147T1 true ATE356147T1 (de) 2007-03-15

Family

ID=4168495

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02708075T ATE356147T1 (de) 2001-03-15 2002-03-14 Antikörper zur vorbeugung und behandlung von e. coli aeec krankheiten

Country Status (9)

Country Link
US (3) US7445782B2 (de)
EP (1) EP1368379B1 (de)
AT (1) ATE356147T1 (de)
AU (1) AU2002242531B8 (de)
BR (1) BRPI0208124B8 (de)
CA (1) CA2339436A1 (de)
DE (1) DE60218636T2 (de)
ES (1) ES2283531T3 (de)
WO (1) WO2002074812A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2252438C (en) * 1996-04-19 2011-03-29 Henry M. Jackson Foundation For The Advancement Of Military Medicine Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
CA2339436A1 (fr) * 2001-03-15 2002-09-15 Josee Harel Production d'anticorps contre les facteurs de virulence associes aux souches d'escherichia coli aeec, et leur utilisation
US7204874B2 (en) 2001-10-24 2007-04-17 Pentron Clinical Technologies, Llc Root canal filling material
US7303817B2 (en) 2001-10-24 2007-12-04 Weitao Jia Dental filling material
US7750063B2 (en) 2001-10-24 2010-07-06 Pentron Clinical Technologies, Llc Dental filling material
US20070009537A1 (en) * 2002-11-14 2007-01-11 Paul Wentworth Antimicrobial activity of antibodies producing reactive oxygen species
MY164281A (en) 2010-11-23 2017-11-30 Pantheryx Inc Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications
WO2013009843A1 (en) * 2011-07-11 2013-01-17 Camas Incorporated Compositions against bacterial toxins
CN102940875B (zh) * 2012-10-31 2015-09-30 中国人民解放军军事医学科学院微生物流行病研究所 Paa蛋白及由其制备的抗体与应用
EP2943211A4 (de) * 2012-12-19 2017-01-25 David Boone Verwendung eines gastrokinproteins
CN105754919B (zh) * 2016-03-22 2019-08-30 南方医科大学 一种ehec o157：h7重组嗜酸乳杆菌载体疫苗及其制备方法和应用
US10772141B2 (en) 2018-06-28 2020-09-08 The Chinese University Of Hong Kong System and method for peer-to-peer wireless communication
WO2020176637A1 (en) 2019-02-26 2020-09-03 Pantheryx, Inc. Compositions for management of disorders of the gastrointestinal tract

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4550019A (en) * 1978-03-22 1985-10-29 South Africa Inventions Development Corporation Manufacture and use of fowl egg antibodies
US4748018A (en) * 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
US5932250A (en) 1982-06-03 1999-08-03 Dcv, Inc. Anti-cholesterolemic egg, vaccine and method for production, and use
JPH0832868B2 (ja) * 1990-01-16 1996-03-29 豊田合成株式会社 液圧シリンダ用シール部品
CA2078716A1 (en) * 1992-09-21 1994-03-22 Joyce De Azavedo Attaching and effacing protein of enterohemorrhagic e. coli
US5367054A (en) * 1993-04-12 1994-11-22 Stolle Research & Development Corp. Large-scale purification of egg immunoglobulin
US5585098A (en) 1993-11-23 1996-12-17 Ovimmune, Inc. Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants
DE9404859U1 (de) 1994-03-22 1995-07-20 Diehl Remscheid GmbH & Co., 42857 Remscheid Verbindung zwischen einem elastischen Gummiteil mit einem harten Kunststoffteil
WO1996000233A1 (en) * 1994-06-24 1996-01-04 Children's Hospital And Medical Center Escherichia coli o157:h7 epithelial adhesin
CA2218601A1 (en) * 1995-03-24 1996-10-03 Ophidian Pharmaceuticals, Inc. Treatment for verotoxin-producing escherichia coli
US5972721A (en) * 1996-03-14 1999-10-26 The United States Of America As Represented By The Secretary Of The Air Force Immunomagnetic assay system for clinical diagnosis and other purposes
CA2252438C (en) * 1996-04-19 2011-03-29 Henry M. Jackson Foundation For The Advancement Of Military Medicine Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
ES2389625T3 (es) 1996-04-23 2012-10-29 The University Of British Columbia Vacuna que comprende la proteína EspA asociada a Escherichia coli patógena
US5741489A (en) * 1996-05-24 1998-04-21 Anitox Corporation Passively administered antibody that enhances feed conversion efficiency
NZ335170A (en) * 1996-10-02 2001-08-31 Ovimmune Inc Oral administration of chicken yolk Ig-gamma antibodies to treat disease
US6204004B1 (en) * 1997-03-21 2001-03-20 University Of Maryland, Baltimore Immunodiagnostic test for enterohemorrhagic Escherichia coli infection
JPH10298105A (ja) 1997-04-23 1998-11-10 Gen Corp:Kk 腸管出血性大腸菌による感染症の予防剤および治療剤
PT1029054E (pt) 1997-11-12 2009-11-11 Univ British Columbia Hp90: receptor membranar do hospedeiro para bactérias patogénicas codificado pelo gene bacteriano tir
US7208574B1 (en) * 1997-11-12 2007-04-24 The University Of British Columbia Host receptor for pathogenic bacteria
GB9803322D0 (en) 1998-02-16 1998-04-15 Imperial College Methods
DE19910159A1 (de) 1999-02-26 2000-09-14 Rosemarie Heis Spezifische lgY-Eidotterantikörper, ihre Gewinnung und ihre Verwendung
US6291435B1 (en) * 1999-03-04 2001-09-18 The Governs Of The University Of Alberta Treatment of diarrhea caused by enteropathogenic Escherichia coli
US7241443B1 (en) * 1999-07-15 2007-07-10 Camas Incorporated Immunogen adherence inhibitor and method of making and using same
US6162441A (en) * 1999-12-15 2000-12-19 Republic Of Korea (Management: Rural Development Administration) Method for the production of anti-escherichia. coli O157 : H7 antibody
CA2395840A1 (en) * 1999-12-27 2001-07-05 The University Of Manitoba Genetic vaccines for the production of chicken egg-yolk antibodies against enterotoxigenic escherichia coli and other pathogens
US6569447B2 (en) * 2000-03-24 2003-05-27 Trouw Nutrition Usa, Llc Combination of plasma and hyperimmunized products for increased performance
US8173783B2 (en) * 2000-12-08 2012-05-08 Good Biotech Corporation Process for selectively isolating IgY antibodies from egg yolk of an anseriform bird and IgY antibodies obtained thereby
NZ527322A (en) * 2001-01-04 2005-07-29 Univ Saskatchewan EHEC cell culture supernatant vaccine
US20030185856A1 (en) * 2001-01-05 2003-10-02 Nam-Hyung Lee Method for the production of the egg containing anti-pathogenic bacteria specific antbodies(igy) and the yogurt and ice cream containing the igy
US6939954B2 (en) * 2001-01-30 2005-09-06 The Lauridsen Group Incorporated Isolated bovine lgG heavy chain protein and its use as an antimicrobial
CA2339436A1 (fr) * 2001-03-15 2002-09-15 Josee Harel Production d'anticorps contre les facteurs de virulence associes aux souches d'escherichia coli aeec, et leur utilisation
IL148598A (en) * 2002-03-10 2008-04-13 Ely Morag Multifunctional complex for targeting specific phagocytosis of a target agent and a composition comprising it
AU2004274977B2 (en) * 2003-09-19 2011-06-23 Epitopix, Llc Campylobacter polypeptides and methods of use
CA2566617C (en) * 2004-05-14 2013-12-31 Agtech Products, Inc. Method and composition for reducing e.coli disease and enhancing performance using bacillus
US7250261B2 (en) * 2004-05-20 2007-07-31 University Of Massachusetts EspFu nucleic acids and proteins and uses thereof

Also Published As

Publication number Publication date
US20100183627A1 (en) 2010-07-22
EP1368379B1 (de) 2007-03-07
AU2002242531B2 (en) 2007-09-20
BRPI0208124B8 (pt) 2022-05-10
WO2002074812A2 (en) 2002-09-26
EP1368379A2 (de) 2003-12-10
DE60218636T2 (de) 2007-11-15
US20090092621A1 (en) 2009-04-09
US20040086513A1 (en) 2004-05-06
DE60218636D1 (de) 2007-04-19
CA2339436A1 (fr) 2002-09-15
BRPI0208124B1 (pt) 2018-02-06
ES2283531T3 (es) 2007-11-01
US7445782B2 (en) 2008-11-04
US8623372B2 (en) 2014-01-07
AU2002242531B8 (en) 2008-04-03
US7727531B2 (en) 2010-06-01
WO2002074812A3 (en) 2003-08-21
BR0208124A (pt) 2004-03-09

Similar Documents

Publication Publication Date Title
ATE356147T1 (de) Antikörper zur vorbeugung und behandlung von e. coli aeec krankheiten
DK1212422T3 (da) Humane CTLA-4-antistoffer og anvendelserne deraf
EP1427744A4 (de) System zur antikörperexpression und- synthese
DK1368060T3 (da) HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
EA200100524A1 (ru) Амиды антраниловой кислоты и их применение в качестве лекарственных средств
CY1113243T1 (el) Μεθοδοι θεραπειας με χρηση αντισωματων cτlα-4
EP1539228A4 (de) Neue zusammensetzung und verfahren zur behandlung von immunerkrankungen
CY1108578T1 (el) Φαρμακευτικες συνθεσεις (κιτ) περιλαμβανοντας ενωσεις διϋδροπυριδινονης και εναν ανοσορυθμιστικο (ή εναν αντιφλεγμονωδη) παραγοντα και οι χρησεις αυτων
WO2004047728A3 (en) Compositions and methods for the treatment of immune related diseases
WO2004039956A3 (en) Compositions and methods for the treatment of immune related diseases
ATE405564T1 (de) 1h-imidazoä4,5-cüchinolinderivate zur behandlung von protein kinase-abhängigen krankheiten
AU2002305450A1 (en) Proteomimetic compounds and methods
BR0012919A (pt) Vacina para uso na profilaxia e/ou no tratamento da sìndrome de ponto branco (white spot syndrome) em crustáceos, proteìna estrutural derivada do vìrus da sìndrome de ponto branco, sequência de ácido nucléico, uso de uma proteìna estrutural, composição farmacêutica, anticorpos, vacina ou formulação farmacêutica, e, kit diagnóstico para detecção de wssv
EP1412388A4 (de) Von dd 3b6/22 abgeleitete humanisierte antikörper mit spezifität für das d-dimer fragment von fibrin
WO2004024072A3 (en) Novel compositions and methods for the treatment of immune related diseases
ATE449847T1 (de) Hepatitis c rezeptorprotein cd81
DK0845034T3 (da) Peptid med pronociceptive egenskaber
HUP0103587A1 (hu) Eljárások és készítmények az F18 Escherichia coli-hoz kapcsolódó betegségekre rezisztens sertések azonosítására
BR9916549A (pt) Composição farmacêutica, vacina, proteìna, e, método para a prevenção ou tratamento de leishmaniose em um humano ou animal
DK0649433T3 (da) Antigeniske regioner fra komplekser af tumorfrigivne partikler (TLP) og antistoffer mod sådanne.
DE60107888D1 (de) Beta-Interferon zur Behandlung von Immunerkrankungen
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
HUP0401586A2 (hu) Baktériumellenes szer
EE200000478A (et) Peptiid, seda kodeeriv geen, diagnostiline reagent ja diagnostiline reaktiivikomplekt ning vaktsiinkasutamiseks riketsioosi ravis
DE69829995D1 (de) Multivalente rekombinante antikörper zur behandlung von hrv infektionen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties